Inhibition of Alveoloar Bone Loss During Maturation of the Rat
1986
The effects of dichloromethylene diphosphonate (C12MDP) on previously described maturational bone loss were quantified in 24 Wistar rats. Four groups of six animals each were treated daily from 18 to 28 weeks of age with a subcutaneous injection of a 0.1, 1.0 or 10mg/kg dose of C12MDP or were sham treated with 0.9% NaC1. Prior to sacrifice, all animals were double-labeled with tetracycline. The interdental bone between first and second maxillary molars was evaluated on decalcified stained sections and on undecalcified ground sections by digitizing morphometry. No significant differences in periodontal ligament width, bone height, osteoclast numbers or tetracycline labeled surface were detected. Significantly greater bone area (p<0.01) and bone width (p<0.005), and significantly fewer osteoblasts/mm of bone surface (p<0.001) were measured in rats treated with 10 mg/kg doses of C12MDP; and a dose response was demonstrated. It was concluded that C12MDP prevented interdental bone loss by inhibiting bone resorption, and that bone formation may have been indirectly reduced through a coupling mechanism.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
4
Citations
NaN
KQI